ATYR PHARMA INC (ATYR)
US0021202025 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | -100.00% | 10.386M | 353K -96.60% | 246.503K -30.17% | 2.911M 1,080.92% | 38.195M 1,212.09% | 165.45M 333.17% | 332.79M 101.14% | 627.31M 88.50% | 904.49M 44.19% | 881.3M -2.56% | 1.118B 26.86% | |
| EBITDA YoY % growth | -33.54M -118.62% | -46.172M -37.66% | -54.327M -17.66% | -67.575M -24.39% | -78.744M -16.53% | -75.174M 4.53% | 37.74M 150.20% | 68.34M 81.08% | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -34.015M -113.78% | -46.404M -36.42% | -54.919M -18.35% | -71.915M -30.95% | -72.894M -1.36% | -65.988M 9.47% | 29.611M 144.87% | 172.56M 482.76% | 429.34M 148.81% | 670.28M 56.12% | 745.49M 11.22% | 977.76M 31.16% | |
| Operating Margin | N/A | -446.79% | -15,557.79% | -29,173.98% | -2,504.09% | -172.77% | 17.90% | 51.85% | 68.44% | 74.11% | 84.59% | 87.46% | |
| EPS YoY % growth | -1.88 -18.24% | -1.60 14.89% | -0.96 40.00% | -0.93 2.91% | -0.82 12.04% | -0.64 22.08% | 0.45 170.79% | 1.96 333.50% | 4.66 137.81% | 6.44 38.18% | 8.29 28.74% | 10.85 30.81% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.24 4.99% | -0.25 -8.65% | -0.25 -8.65% | -0.19 15.74% | -0.18 22.70% | -0.21 14.29% | -0.20 18.37% | -0.11 42.11% | 0.02 111.11% |
| Revenue Q2Q % growth | 14.576K | -100.00% | -100.00% | 7.65M | 19.87M | ||||
| EBITDA Q2Q % growth | -18.768M -22.13% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -18.815M -17.89% | -19.5M -17.22% | -19.675M -13.63% | -20.984M -15.66% | -21.296M -13.19% | -16.94M 13.13% | -15.834M 19.52% | -8.476M 59.61% | 1.542M 107.24% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.23 -15.00% | -0.22 | -0.01 | -2.50% |
| Q2 2024 Q2Q % growth | -0.23 -4.55% | -0.24 | 0.01 | 5.26% |
| Q1 2024 Q2Q % growth | -0.23 20.69% | -0.24 | 0.01 | 4.45% |
| Q4 2023 Q2Q % growth | -0.25 3.85% | -0.24 | -0.01 | -2.98% |
| Q3 2023 Q2Q % growth | -0.20 56.52% | -0.23 | 0.03 | 13.24% |
| Q2 2023 Q2Q % growth | -0.22 50.00% | -0.28 | 0.06 | 22.57% |
| Q1 2023 Q2Q % growth | -0.29 34.09% | -0.41 | 0.12 | 28.62% |
| Q4 2022 Q2Q % growth | -0.26 16.13% | -0.49 | 0.23 | 46.90% |
| Q3 2022 Q2Q % growth | -0.46 -9.52% | -0.47 | 0.01 | 2.32% |
| Q2 2022 Q2Q % growth | -0.44 31.25% | -0.39 | -0.05 | -12.92% |
| Q1 2022 Q2Q % growth | -0.44 13.73% | -0.34 | -0.10 | -30.06% |
| Q4 2021 Q2Q % growth | -0.31 34.04% | -0.29 | -0.02 | -7.27% |
| Q3 2021 Q2Q % growth | -0.42 38.24% | -0.61 | 0.19 | 30.88% |
| Q2 2021 Q2Q % growth | -0.64 7.25% | -0.52 | -0.12 | -23.51% |
| Q1 2021 Q2Q % growth | -0.51 -304.00% | -0.32 | -0.19 | -57.48% |
| Q4 2020 Q2Q % growth | -0.47 69.48% | -0.84 | 0.37 | 44.03% |
| Q3 2020 Q2Q % growth | -0.68 53.74% | -0.76 | 0.08 | 10.31% |
| Q2 2020 Q2Q % growth | -0.69 61.67% | -0.74 | 0.05 | 7.33% |
| Q1 2020 Q2Q % growth | 0.25 109.92% | -0.18 | 0.43 | 236.17% |
| Q4 2019 Q2Q % growth | -1.54 | -1.62 | 0.08 | 5.04% |
| Q3 2019 Q2Q % growth | -1.47 | -1.76 | 0.29 | 16.53% |
| Q2 2019 Q2Q % growth | -1.80 | -2.80 | 1.00 | 35.69% |
| Q1 2019 Q2Q % growth | -2.52 | -3.23 | 0.71 | 21.92% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -100.00% | 17.003K | -17.003K | -100.00% |
| Q2 2024 Q2Q % growth | 24.48K | -24.48K | -100.00% | |
| Q1 2024 Q2Q % growth | 235K | 20.4K | 214.6K | 1,051.96% |
| Q4 2023 Q2Q % growth | -100.00% | 53.04K | -53.04K | -100.00% |
| Q3 2023 Q2Q % growth | 353K | 1.53M | -1.177M | -76.93% |
| Q2 2023 Q2Q % growth | 534.776K | -534.776K | -100.00% | |
| Q1 2023 Q2Q % growth | 309.397K | -309.397K | -100.00% | |
| Q4 2022 Q2Q % growth | 10.386M | 218.576K | 10.167M | 4,651.67% |
| Q3 2022 Q2Q % growth | 339.997K | -339.997K | -100.00% | |
| Q2 2022 Q2Q % growth | 2.04M | -2.04M | -100.00% | |
| Q1 2022 Q2Q % growth | 170.003K | -170.003K | -100.00% | |
| Q4 2021 Q2Q % growth | -100.00% | 3.08M | -3.08M | -100.00% |
| Q3 2021 Q2Q % growth | -100.00% | 233.141K | -233.141K | -100.00% |
| Q2 2021 Q2Q % growth | -100.00% | 634.236K | -634.236K | -100.00% |
| Q1 2021 Q2Q % growth | -100.00% | 4.064M | -4.064M | -100.00% |
| Q4 2020 Q2Q % growth | 2.053M 1,325.69% | 128.52K | 1.924M | 1,497.42% |
| Q3 2020 Q2Q % growth | 148K -19.57% | 105.397K | 42.603K | 40.42% |
| Q2 2020 Q2Q % growth | 189K 101.06% | 406.98K | -217.98K | -53.56% |
| Q1 2020 Q2Q % growth | 8.065M | 4.487M | 3.578M | 79.74% |
| Q4 2019 Q2Q % growth | 144K | 158.783K | -14.783K | -9.31% |
| Q3 2019 Q2Q % growth | 184K | 61.2K | 122.8K | 200.65% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -3.04% | 0.52% | 0.46% |
| Revenue | 0% | 257.25% | -4.69% | -16.09% |